Results 141 to 150 of about 27,250 (275)

Buckling of the left common carotid artery simulating mediastinal neoplasm [PDF]

American Journal of Roentgenology, 1979
B D Toombs, CM Sandler, R G Lester
openaire   +3 more sources

Malignant phyllodes tumours of the breast: the case for revising WHO’s ‘full house’ diagnostic criteria

Histopathology, Volume 87, Issue 2, Page 169-182, August 2025.
This review explores the histological criteria used in classifying malignant phyllodes tumours, current evidence gaps in relation to their metastatic potential and survey data of international breast pathologists to propose a refined diagnostic approach.
Puay Hoon Tan, Ian O Ellis, Kimberly H Allison, Sunil S Badve, Edi Brogi, Grace Callagy, Emmanuelle Charafe‐Jauffret, Chih‐Jung Chen, Yunn‐Yi Chen, Laura C Collins, Gábor Cserni, Lounes Djerroudi, Maria Pia Foschini, Stephen B Fox, Helenice Gobbi, Mihir Gudi, Oi Harada, Shabnam Jaffer, Janina Kulka, Hajime Kuroda, Sunil R Lakhani, Xiaoxian Li, Takuya Moriya, Sandra O'Toole, Sarah E Pinder, Elena Provenzano, Cecily Quinn, Wendy Raymond, Aysegul A Sahin, Fernando Schmitt, Abeer M Shaaban, Tanuja Shet, Kalliopi P Siziopikou, Ping Tang, Gary M Tse, Zsuzsanna Varga, Anne Vincent‐Salomon, Hannah Wen, Rin Yamaguchi, Wentao Yang, Stuart J Schnitt, Emad A Rakha   +41 more
wiley   +1 more source

Mediastinal Hemangioma Mimicking Thymic Tumour. [PDF]

Respirol Case Rep
Jeong J, Kang MK.
europepmc   +1 more source

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll‐Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double‐Blind, Placebo‐Controlled Study

ACR Open Rheumatology, Volume 7, Issue 7, July 2025.
Objective There is an unmet need for safe and effective oral treatments for cutaneous lupus erythematosus (CLE). Afimetoran is an investigational, first‐in‐class, orally bioavailable, selective small molecule inhibitor of Toll‐like receptors (TLRs) 7 and 8.
Fareeda Hosein, Stanislav Ignatenko, Kristina D. Chadwick, Lin Zhu, Frédéric Baribaud, Jasmine Saini, Thanh Bach, Urvi Aras, WanYing Zhang, Hazem Karabeber, Michelle Dawes, Melanie Harrison, Leonidas N. Carayannopoulos, Gopal Krishna   +13 more
wiley   +1 more source

Prognostic factors for patients with esophageal cancer who achieve pathological complete response in the primary tumor after upfront chemotherapy or chemoradiotherapy

Annals of Gastroenterological Surgery, Volume 9, Issue 4, Page 678-686, July 2025.
Male gender and pathological lymph node metastasis are independent poor prognostic factors in patients with esophageal cancer who receive upfront treatment followed by surgery and achieved pathological complete response of the primary tumor. Among patients without pathological lymph node metastasis, the upfront chemotherapy group showed significantly ...
Masaaki Motoori, Koji Tanaka, Hiroshi Miyata, Makoto Yamasaki, Osamu Shiraishi, Atsushi Takeno, Tomoki Makino, Keijiro Sugimura, Takushi Yasuda, Yuichiro Doki   +9 more
wiley   +1 more source

Dedifferentiated liposarcoma of the anterior mediastinum: An uncommon case presentation and complex diagnosis. [PDF]

Radiol Case Rep
Crawford CK, Arshad H, Fishman EK.
europepmc   +1 more source

Pulmonary Blastoma: A Case Report and Review of the Literature

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT This report aimed to underscore the significance of pulmonary blastoma, a rare entity with limited literature, by contributing insights into its clinical features, diagnostic approaches, and treatment modalities. Additionally, it emphasizes the critical role of a multidisciplinary approach in the effective management of this complex and ...
Haseeb Ahsin, Farwa Aftab, Alishba Amjad, Sumbal Saeed, Fattahullah Khan   +4 more
wiley   +1 more source

Concurrent Bone Marrow Acute Undifferentiated Leukemia and Mediastinal T-Lymphoblastic Lymphoma With Identical <i>SET::NUP214</i> Fusion and <i>PHF6</i> and <i>EZH2</i> Mutations. [PDF]

EJHaem
Wei Q, Jelloul FZ, Wang SA, Tang G, Li S, Lin P, Loghavi S, Wang HY, Medeiros LJ, Xu J.   +9 more
europepmc   +1 more source

First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors

Cancer, Volume 131, Issue 13, 1 July 2025.
Abstract Background Indoleamine 2,3‐dioxygenase 1 (IDO1) is a heme‐containing enzyme that degrades tryptophan (Trp) to kynurenine (Kyn), which suppresses effector T cells and reduces antitumor activity. KHK2455 is a long‐acting selective IDO1 inhibitor that blocks the heme component of the IDO holoenzyme.
Timothy A. Yap, Olivier Rixe, Capucine Baldini, Ursa Brown‐Glaberman, Sergey Efuni, David S. Hong, Christophe Massard, Jameel Muzaffar, Andreea Varga, Emrullah Yilmaz, Yuta Ikawa, Lisa H. Shiue, Yi Liu, Matthew W. Hruska, Henry Zhao, Akihiro Tokunaga, Solmaz Sahebjam   +16 more
wiley   +1 more source

Synchronous Thymoma and Esophageal Cancer Treated With Minimally Invasive Unilateral Video-Assisted Thoracoscopic Surgery: A Case Report. [PDF]

Cureus
Okamoto K, Kikunaga S, Karasaki T, Ogawa Y, Ohkura Y, Honda A, Fujimori S, Ueno M, Udagawa H.   +8 more
europepmc   +1 more source